0000950170-24-042010.txt : 20240404 0000950170-24-042010.hdr.sgml : 20240404 20240404201335 ACCESSION NUMBER: 0000950170-24-042010 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240402 FILED AS OF DATE: 20240404 DATE AS OF CHANGE: 20240404 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BB BIOTECH AG CENTRAL INDEX KEY: 0000924223 ORGANIZATION NAME: STATE OF INCORPORATION: V8 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32979 FILM NUMBER: 24824478 BUSINESS ADDRESS: STREET 1: SCHWERTSTRASSE 6 CITY: SCHAFFHAUSEN STATE: V8 ZIP: 8200 BUSINESS PHONE: 411724 59 59 MAIL ADDRESS: STREET 1: SCHWERTSTRASSE 6 CITY: SCHAFFHAUSEN STATE: V8 ZIP: 8200 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BIOTECH TARGET N V CENTRAL INDEX KEY: 0001259870 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32979 FILM NUMBER: 24824479 MAIL ADDRESS: STREET 1: ARA HILL TOP BUILDING, UNIT A-5 STREET 2: PLETTERIJWEG OOST 1, CURACAO CITY: WILLEMSTAD STATE: P8 ZIP: 000000 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Molecular Templates, Inc. CENTRAL INDEX KEY: 0001183765 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 943409596 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9301 AMBERGLEN BLVD STREET 2: SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78729 BUSINESS PHONE: 512 896 1555 MAIL ADDRESS: STREET 1: 9301 AMBERGLEN BLVD STREET 2: SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78729 FORMER COMPANY: FORMER CONFORMED NAME: THRESHOLD PHARMACEUTICALS INC DATE OF NAME CHANGE: 20020828 4 1 ownership.xml 4 X0508 4 2024-04-02 0001183765 Molecular Templates, Inc. MTEM 0001259870 BIOTECH TARGET N V ARA HILL TOP BUILDING, UNIT A-5, PLETTERIJWEG OOST 1 CURACAO P8 00000 NETHERLANDS ANTILLES false false true false 0000924223 BB BIOTECH AG SCHWERTSTRASSE 6 SCHAFFHAUSEN V8 CH-8200 SWITZERLAND false false true false false Common Stock 2024-04-02 4 P false 250000 2.35 A 1279820 D Prefunded Warrants (right to buy) 0.001 2024-04-02 4 P false 134667 2.349 A 2024-04-02 2029-04-02 Common Stock 134667 134667 D Common Warrants (right to buy) 2.35 2024-04-02 4 P false 769334 0.125 A 2024-04-02 Common Stock 769334 769334 D The Common Warrants have a term of five years and the Prefunded Warrants will expire when fully exercised in accordance with their terms. The Prefunded and Common Warrants may not be exercised if the aggregate number of shares of Common Stock beneficially owned by the holder thereof immediately following such exercise would exceed 19.99% of the number of the shares of Common Stock outstanding immediately following such exercise. Biotech Target N.V. is a wholly-owned subsidiary of BB Biotech AG. Accordingly, BB Biotech AG may be deemed to be the indirect beneficial owner of the securities of Molecular Templates, Inc. held directly or indirectly by Biotech Target N.V. This Form 4 is filed jointly by BB Biotech AG and Biotech Target N.V. By: /s/Ivo Betschart 2024-04-04 By: /s/ Martin Gubler 2024-04-04